Chatterjee et al. 2019
Back to overview
Chatterjee P, Srivastava AK, Kumar DA, Chakrawarty A, Khan MA, Ambashtha AK, Kumar V, De Taboada L, Dey AB. Effect of deep tissue laser therapy treatment on peripheral neuropathic pain in older adults with type 2 diabetes: a pilot randomized clinical trial. BMC Geriatr. 2019 Aug 12;19(1):218.
Design: Randomized, double-masked, sham-controlled, interventional trial. Subjects: 40 patients with type 2 diabetes with painful diabetic peripheral neuropathy. Methods: patients were randomised to receive either: • Deep Tissue Laser Treatment (DTLT) (n=20) with LightForce HPL or • Sham laser treatment (SLT) (n=20). SLT treatment was identical to DTLT treatment, except in that in SLT, the laser emission was disabled. All patients were treated 2x/week for 4 weeks and then 1x/week for 8 weeks (12 weeks in total). All subjects received standard-of-care also. Results: • After the 12-week intervention period, pain levels significantly decreased in both groups and were significantly lower in the DTLT group than in the SLT group. • The Timed Up and Go test times (assessing functionality) were significantly improved in both groups and were 16% shorter in the DTLT group than in the SLT group. • Patients' quality of life improved significantly in the DTLT group but not in the SLT group. • No adverse events were reported.
Key message: Deep tissue laser therapy significantly reduced pain and improved the quality of life of older patients with painful diabetic peripheral neuropathy.
iEnovis
Pubmed
30
© 2022 Enovis Corporation
CONFIDENTIAL
Made with FlippingBook - PDF hosting